|
|
|
|
| Top Story |
 |
|
The EFPIA Disclosure Experience: An Update |
Nine months on from the 2016 EFPIA Disclosure Code deadline — requiring all member companies to publish data concerning their transfer-of-value transactions to HCPs —EFPIA offered an update on media and industry responses at a recent conference in London.
... /Read more/ |
|
|
| Advertisement |
Changing the functional role of capsules
By combining polymer science, engineering and formulation know-how, Capsugel is creating breakthroughs in capsule and encapsulation technologies that are changing the functional role of capsules in medical research, drug formulation and drug delivery.
 Learn more
|
|
| Europe |
 |
|
EMA Guidance on RMPs in the EU |
EMA released the revised Module V- Risk Management Systems (Rev 2) of Good Pharmacovigilance Practice (GVP) (EMA/838713/2011 Rev 2) accompanied by a revised Guidance on the format of the risk management plan (RMP) in the EU.
... /Read more/ |
|
|
|
ADVERTISEMENT
|
|
ADVERTISEMENT
|
| Industry update |
| //UDG Healthcare announced the appointment of Jez Moulding as Chief Operating Officer of UDG and Executive Vice President of Ashfield, effective May 2, 2017.//Recipharm (Stockholm, Sweden) announced the appointment of Henrik Stenqvist Executive Vice President and Chief Financial Officer.//Aelix Therapeutics (Barcelona, Spain) appointed Dr. Ian McGowan as Chief Medical Officer.//Allecra Therapeutics (Lörrach, Germany and Saint Louis, France) named Dr. Engelbert (Bert) Tjeenk Willink as Chairman of the Board and Dr. Leon Hooftman as Chief Medical Officer. Dr. Holger Reithinger of Forbion Partners steps down as Chairman and remains on Allecra's Advisory Board.// |
|
|
|
